Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

About us Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of both rare and prevalent diseases.

News

Amarna Therapeutics appointed new CEO
Dutch Amarna Therapeutics has appointed Dr Steen Klysner. The new CEO has been active in the biotech industry for more than 30 years
Read more
Report